Important highlight from Alere’s Q4 earnings session:
“Additionally, in January we launched our Cardiorenal panel in Europe, for use on the Triage platform. The Cardiorenal panel is the world’s first point of care test to combine BNP and NGAL to aid in the real-time assessment of cardiac and renal status. We believe this panel will continue to support greater adoption of NGAL as a novel biomarker for the evaluation of kidney function.”
